Astrid Fahrleitner-Pammer

Ontology type: schema:Person     

Person Info





Publications in SciGraph latest 50 shown

  • 2022-11-11 Osteoporosis treatment in Austria—assessment of FRAX-based intervention thresholds for high and very high fracture risk in ARCHIVES OF OSTEOPOROSIS
  • 2022-09-29 Romosozumab efficacy and safety in European patients enrolled in the FRAME trial in OSTEOPOROSIS INTERNATIONAL
  • 2022-03-09 Usefulness of the trabecular bone score in maintenance dialysis patients in WIENER KLINISCHE WOCHENSCHRIFT
  • 2021-08-15 Thirty years of hip fracture incidence in Austria: is the worst over? in OSTEOPOROSIS INTERNATIONAL
  • 2020-09-18 Morphometric parameters of muscle and bone in critically ill patients in WIENER KLINISCHE WOCHENSCHRIFT
  • 2020-05-30 Efficacy of teriparatide compared with risedronate on FRAX®-defined major osteoporotic fractures: results of the VERO clinical trial in OSTEOPOROSIS INTERNATIONAL
  • 2020-03-10 Distribution of Prevalent and Incident Vertebral Fractures and Their Association with Bone Mineral Density in Postmenopausal Women in the Teriparatide Versus Risedronate VERO Clinical Trial in CALCIFIED TISSUE INTERNATIONAL
  • 2019-06-14 Long-term denosumab treatment restores cortical bone loss and reduces fracture risk at the forearm and humerus: analyses from the FREEDOM Extension cross-over group in OSTEOPOROSIS INTERNATIONAL
  • 2019-01-18 Serum 25-hydroxy-vitamin D and the risk of fractures in the teriparatide versus risedronate VERO clinical trial in ARCHIVES OF OSTEOPOROSIS
  • 2018-12-01 Assessing the effects of long-term osteoporosis treatment by using conventional spine radiographs: results from a pilot study in a sub-cohort of a large randomized controlled trial in SKELETAL RADIOLOGY
  • 2018-03-20 Bone-related Circulating MicroRNAs miR-29b-3p, miR-550a-3p, and miR-324-3p and their Association to Bone Microstructure and Histomorphometry in SCIENTIFIC REPORTS
  • 2017-08-25 Effect of vitamin D3 on bone turnover markers in critical illness: post hoc analysis from the VITdAL-ICU study in OSTEOPOROSIS INTERNATIONAL
  • 2017-06-22 Factors associated with high 24-month persistence with denosumab: results of a real-world, non-interventional study of women with postmenopausal osteoporosis in Germany, Austria, Greece, and Belgium in ARCHIVES OF OSTEOPOROSIS
  • 2016-12-17 Teriparatide treatment in a heart transplant patient with a chronic kidney disease and a low-turnover bone disease: a case report in OSTEOPOROSIS INTERNATIONAL
  • 2016-09-26 Serum sclerostin levels in renal cell carcinoma patients with bone metastases in SCIENTIFIC REPORTS
  • 2015-12-01 Bone - a casualty of ICU survival? in CRITICAL CARE
  • 2015-05-28 Persistence, adherence, and medication-taking behavior in women with postmenopausal osteoporosis receiving denosumab in routine practice in Germany, Austria, Greece, and Belgium: 12-month results from a European non-interventional study in OSTEOPOROSIS INTERNATIONAL
  • 2014-06-17 Epidemiology of distal forearm fractures in Austria between 1989 and 2010 in OSTEOPOROSIS INTERNATIONAL
  • 2013-08-22 Effective osteoporosis treatment with teriparatide is associated with enhanced quality of life in postmenopausal women with osteoporosis: the European Forsteo Observational Study in BMC MUSCULOSKELETAL DISORDERS
  • 2013-06-15 Awareness of chronic kidney disease in Austria: a frequently under-recognized clinical picture in WIENER KLINISCHE WOCHENSCHRIFT
  • 2013-04-09 Epidemiology of proximal humeral fractures in Austria between 1989 and 2008 in OSTEOPOROSIS INTERNATIONAL
  • 2013-03-26 Long-term quality of life of liver transplant recipients beyond 60 years of age in GEROSCIENCE
  • 2013-02-13 Incidence of ischemic type biliary lesions after liver transplantation using piggyback technique and retrograde reperfusion in EUROPEAN SURGERY
  • 2012-12-20 Erratum to: Update on denosumab in postmenopausal osteoporosis—recent clinical data in WIENER MEDIZINISCHE WOCHENSCHRIFT
  • 2012-09-13 Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: a randomized, double-blind, placebo-controlled trial in BMC ENDOCRINE DISORDERS
  • 2012-06-12 Update on denosumab in postmenopausal osteoporosis—recent clinical data in WIENER MEDIZINISCHE WOCHENSCHRIFT
  • 2012-04-14 Homoarginine deficiency is associated with increased bone turnover in OSTEOPOROSIS INTERNATIONAL
  • 2012-04-01 Effectiveness of Teriparatide in Women Over 75 Years of Age with Severe Osteoporosis: 36-Month Results from the European Forsteo Observational Study (EFOS) in CALCIFIED TISSUE INTERNATIONAL
  • 2012-03-17 Associations of homoarginine with bone metabolism and density, muscle strength and mortality: cross-sectional and prospective data from 506 female nursing home patients in OSTEOPOROSIS INTERNATIONAL
  • 2012-02 Effetti del teriparatide in donne osteoporotiche post-menopausali precedentemente trattate con bifosfonati: risultati a 36 mesi (European Forsteo Observational Study) in L'ENDOCRINOLOGO
  • 2011-09-15 Osteoporosis, weight gain and atypical fat accumulations – a typical feature not only for Cushing's, but also Madelung's disease: A case report in WIENER KLINISCHE WOCHENSCHRIFT
  • 2011-09-02 The role of osteoprotegerin (OPG) receptor activator for nuclear factor kappaB ligand (RANKL) in cardiovascular pathology – a review in WIENER MEDIZINISCHE WOCHENSCHRIFT
  • 2010-12 Österreichischer Leitfaden zur medikamentösen Therapie der postmenopausalen Osteoporose: Addendum 2010 in WIENER MEDIZINISCHE WOCHENSCHRIFT
  • 2010-11-27 Fracture rate and back pain during and after discontinuation of teriparatide: 36-month data from the European Forsteo Observational Study (EFOS) in OSTEOPOROSIS INTERNATIONAL
  • 2010-10-20 Low bone turnover and increase of bone mineral density in a premenopausal woman with postoperative hypoparathyroidism and thyroxine suppressive therapy in OSTEOPOROSIS INTERNATIONAL
  • 2010-08-23 Pharmacologic undertreatment of osteoporosis in Austrian nursing homes and senior's residences in WIENER KLINISCHE WOCHENSCHRIFT
  • 2010-08-16 Levels of osteoprotegerin (OPG) and receptor activator for nuclear factor kappa B ligand (RANKL) in serum: Are they of any help? in WIENER MEDIZINISCHE WOCHENSCHRIFT
  • 2010-06 Reversal in the secular trend of hip fracture incidences in Austria in WIENER KLINISCHE WOCHENSCHRIFT
  • 2010-05-11 Epidemiology of hip fractures in Austria: evidence for a change in the secular trend in OSTEOPOROSIS INTERNATIONAL
  • 2010-02-05 Histomorphometric changes by teriparatide in alendronate-pretreated women with osteoporosis in OSTEOPOROSIS INTERNATIONAL
  • 2010-01-08 Vitamin D deficiency following Billroth II surgery - How much vitamin D is enough?: a case report in CASES JOURNAL
  • 2009-10-13 Reduction in Fracture Rate and Back Pain and Increased Quality of Life in Postmenopausal Women Treated with Teriparatide: 18-Month Data from the European Forsteo Observational Study (EFOS) in CALCIFIED TISSUE INTERNATIONAL
  • 2009-05 Österreichischer Leitfaden zur medikamentösen Therapie der postmenopausalen Osteoporose – Update 2009 in WIENER MEDIZINISCHE WOCHENSCHRIFT. SUPPLEMENT
  • 2009-04-07 Graz Endocrine Causes of Hypertension (GECOH) study: a diagnostic accuracy study of aldosterone to active renin ratio in screening for primary aldosteronism in BMC ENDOCRINE DISORDERS
  • 2008-07-16 Effects of a long-term vitamin D and calcium supplementation on falls and parameters of muscle function in community-dwelling older individuals in OSTEOPOROSIS INTERNATIONAL
  • 2007-01 Calcium supply, bone mineral density and genetically defined lactose maldigestion in a cohort of elderly men in JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
  • 2006-11-14 Adult-type hypolactasia and calcium availability: decreased calcium intake or impaired calcium absorption? in OSTEOPOROSIS INTERNATIONAL
  • 2006-01-25 Changes in the RANK ligand/osteoprotegerin system are correlated to changes in bone mineral density in bisphosphonate-treated osteoporotic patients in OSTEOPOROSIS INTERNATIONAL
  • 2004-07-31 Hypovitaminosis D, impaired bone turnover and low bone mass are common in patients with peripheral arterial disease in OSTEOPOROSIS INTERNATIONAL
  • 2003-05 Osteoprotegerin serum levels in women: Correlation with age, bone mass, bone turnover and fracture status in WIENER KLINISCHE WOCHENSCHRIFT
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

        "@context": "", 
        "affiliation": [
            "affiliation": {
              "id": "", 
              "type": "Organization"
            "isCurrent": true, 
            "type": "OrganizationRole"
            "id": "", 
            "type": "Organization"
            "id": "", 
            "type": "Organization"
            "id": "", 
            "type": "Organization"
            "id": "", 
            "type": "Organization"
            "id": "", 
            "type": "Organization"
        "familyName": "Fahrleitner-Pammer", 
        "givenName": "Astrid", 
        "id": "sg:person.01004314346.18", 
        "sameAs": [
        "sdDataset": "persons", 
        "sdDatePublished": "2022-12-01T07:14", 
        "sdLicense": "", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/person/person_926.jsonl", 
        "type": "Person"

    Download the RDF metadata as:  json-ld nt turtle xml License info


    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' ''

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' ''

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' ''

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' ''


    This table displays all metadata directly associated to this object as RDF triples.

    26 TRIPLES      10 PREDICATES      16 URIs      7 LITERALS      2 BLANK NODES

    Subject Predicate Object
    1 sg:person.01004314346.18 schema:affiliation N8fea87882a524f3e887162ab835a5ec9
    2 grid-institutes:grid.22937.3d
    3 grid-institutes:grid.263618.8
    4 grid-institutes:grid.411580.9
    5 grid-institutes:grid.5110.5
    6 grid-institutes:grid.6363.0
    7 schema:familyName Fahrleitner-Pammer
    8 schema:givenName Astrid
    9 schema:sameAs
    10 schema:sdDatePublished 2022-12-01T07:14
    11 schema:sdLicense
    12 schema:sdPublisher N4c09a05a9aff4684b7899c7af9799d47
    13 sgo:license sg:explorer/license/
    14 sgo:sdDataset persons
    15 rdf:type schema:Person
    16 N4c09a05a9aff4684b7899c7af9799d47 schema:name Springer Nature - SN SciGraph project
    17 rdf:type schema:Organization
    18 N8fea87882a524f3e887162ab835a5ec9 schema:affiliation grid-institutes:grid.11598.34
    19 sgo:isCurrent true
    20 rdf:type schema:OrganizationRole
    21 grid-institutes:grid.11598.34 schema:Organization
    22 grid-institutes:grid.22937.3d schema:Organization
    23 grid-institutes:grid.263618.8 schema:Organization
    24 grid-institutes:grid.411580.9 schema:Organization
    25 grid-institutes:grid.5110.5 schema:Organization
    26 grid-institutes:grid.6363.0 schema:Organization

    Preview window. Press ESC to close (or click here)